Recepton
|
Year Established:
2016 |
|
|
Website:
receptonbiotech.com |
|
|
Headquarters:
Gdańsk , pomorskie, PL |
|
|
Company Type:
New Startup (0-1M TTM Revenue) |
|
|
Completed Requests:
14 |
|
|
Open Requests:
2 |
|
Certifications:
|
Recepton is a newly founded biotech company focused on cancer immunotherapy, the process of mobilizing the immune system to kill cancer.
In particular, we have designed:
1) a novel service platform composed of a broad portfolio of the recombinant immune checkpoint receptors. The platform can be used for rapid typing and testing of new types of inhibitors for the immunoreceptors, especially for the signaling axis of the programmed cell death protein 1 (PD-1) and its ligand, protein PD-L1.
2) chemistry synthetic and biophysical methods of rational drug design, cell-based assays, preclinical studies that aim at developing new types of small-molecule inhibitors for the immune checkpoint blockade (ICB).
| Site | Badges | |
|---|---|---|
| Recepton 3 Trzy Lipy Gdańsk , pomorskie, 80-172 Poland | ||
| Recepton 2 Gronostajowa Kraków, malopolskie, 30-387 Poland | ||
| Recepton 3 Trzy Lipy Gdańsk, pomorskie, 80-172 Poland | ||
Get started
If your organization has a Scientist.com marketplace, you can log in here to order products and services directly. If you're interested in ordering custom research services from suppliers in the Scientist.com network, book a meeting with our team here. To order products instantly, request access below.